A Somatic Approach to Stage 5 Chronic Kidney Disease: Unbinding Fear and Grief from the Renal System
A naturopathic case exploring how structured somatic medicine can support nervous system regulation, emotional processing, ...
Johnson & Johnson (NYSE:JNJ), a worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-9 study of TECVAYLI® ...
Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of KANDLELIT-007, a ...
Which of the statements about the recent guideline for evaluating and managing peripheral nervous system manifestations of Sjögren disease are correct?
Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...
The drug targets a specific mutation that applies to only 2% of ALS patients. A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS ...
Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing ...
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Standard Market of the Tokyo Stock Exchange ...
With the Official Christmas Number 1 results still fresh in our memory, this week’s Official Chart First Look sees WHAM! and Last Christmas potentially back on top to clinch the final Number 1 of 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback